ID UPPP2_CORJK Reviewed; 290 AA. AC Q4JVN6; DT 21-MAR-2006, integrated into UniProtKB/Swiss-Prot. DT 02-AUG-2005, sequence version 1. DT 16-JUN-2009, entry version 27. DE RecName: Full=Undecaprenyl-diphosphatase 2; DE EC=3.6.1.27; DE AltName: Full=Undecaprenyl pyrophosphate phosphatase 2; DE AltName: Full=Bacitracin resistance protein 2; GN Name=uppP2; OrderedLocusNames=jk0957; OS Corynebacterium jeikeium (strain K411). OC Bacteria; Actinobacteria; Actinobacteridae; Actinomycetales; OC Corynebacterineae; Corynebacteriaceae; Corynebacterium. OX NCBI_TaxID=306537; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15968079; DOI=10.1128/JB.187.13.4671-4682.2005; RA Tauch A., Kaiser O., Hain T., Goesmann A., Weisshaar B., RA Albersmeier A., Bekel T., Bischoff N., Brune I., Chakraborty T., RA Kalinowski J., Meyer F., Rupp O., Schneiker S., Viehoever P., RA Puehler A.; RT "Complete genome sequence and analysis of the multiresistant RT nosocomial pathogen Corynebacterium jeikeium K411, a lipid-requiring RT bacterium of the human skin flora."; RL J. Bacteriol. 187:4671-4682(2005). CC -!- FUNCTION: Catalyzes the dephosphorylation of undecaprenyl CC diphosphate (UPP). Confers resistance to bacitracin (By CC similarity). CC -!- CATALYTIC ACTIVITY: Undecaprenyl diphosphate + H(2)O = CC undecaprenyl phosphate + phosphate. CC -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein CC (By similarity). CC -!- MISCELLANEOUS: Bacitracin is thought to be involved in the CC inhibition of peptidoglycan synthesis by sequestering undecaprenyl CC diphosphate, thereby reducing the pool of lipid carrier available. CC -!- SIMILARITY: Belongs to the uppP family. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; CR931997; CAI37121.1; -; Genomic_DNA. DR RefSeq; YP_250739.1; -. DR GeneID; 3433525; -. DR GenomeReviews; CR931997_GR; jk0957. DR KEGG; cjk:jk0957; -. DR NMPDR; fig|306537.3.peg.417; -. DR HOGENOM; Q4JVN6; -. DR OMA; Q4JVN6; RYISTRT. DR BioCyc; CJEI306537:JK0957-MON; -. DR GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW. DR GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell. DR GO; GO:0050380; F:undecaprenyl-diphosphatase activity; IEA:HAMAP. DR GO; GO:0007047; P:cell wall organization; IEA:UniProtKB-KW. DR GO; GO:0016311; P:dephosphorylation; IEA:InterPro. DR GO; GO:0009252; P:peptidoglycan biosynthetic process; IEA:UniProtKB-KW. DR GO; GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW. DR GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW. DR HAMAP; MF_01006; -; 1. DR InterPro; IPR003824; Bacitracin-R_BacA. DR Pfam; PF02673; BacA; 1. DR TIGRFAMs; TIGR00753; undec_PP_bacA; 1. PE 3: Inferred from homology; KW Antibiotic resistance; Cell membrane; Cell shape; KW Cell wall biogenesis/degradation; Complete proteome; Hydrolase; KW Membrane; Peptidoglycan synthesis; Transmembrane. FT CHAIN 1 290 Undecaprenyl-diphosphatase 2. FT /FTId=PRO_0000227616. FT TRANSMEM 104 124 Potential. FT TRANSMEM 128 148 Potential. FT TRANSMEM 174 194 Potential. FT TRANSMEM 205 225 Potential. FT TRANSMEM 237 257 Potential. FT TRANSMEM 268 288 Potential. SQ SEQUENCE 290 AA; 31766 MW; 7DEAAFF7CCAE65DD CRC64; MTTDMTWAQT IILSLIQGLT EFLPVSSSGH LRIFSTLLWG EDAGASFTAV IQLGTELAVL VFFAKDIWNI ASAWCKGVWE WLTDLTGKHG RRVHRQSFDY RMGWMVIVGT LPVAVLGYLG KDLIRDNLRN LWITATMLVL FSFVFILAER MGRRERSFDE LTMRDSVIMG FAQCLALIPG VSRSGGTVSA GLFLNLDREV ATRYSFLLAI PAVLASGLFS LPDAFSPDAG QAASGAQLFV GTAIAFAVGY ASIAWLLKFV ANHSFAWFAL WRIPLGLAVM GLLAFGVLQA //